| Literature DB >> 25899387 |
Stefanie H Grimm1, Georg Höfner1, Klaus T Wanner2.
Abstract
We herein present label-free, mass-spectrometry-based binding assays (MS Binding Assays) for the human dopamine, norepinephrine, and serotonin transporters (hDAT, hNET, and hSERT). Using this approach both enantiomers of the triple reuptake inhibitor indatraline as well as its cis-configured diastereomer were investigated toward hDAT, hNET, and hSERT in saturation experiments. The dissociation rate constants for (1R,3S)-indatraline binding at hDAT, hNET, and hSERT were determined in kinetic studies. These experiments revealed an allosteric effect of clomipramine on the dissociation of (1R,3S)-indatraline from hSERT. Finally, a comprehensive set of known monoamine transport inhibitors and substrates was studied in competition experiments at hDAT, hNET, and hSERT, using (1R,3S)-indatraline as nonlabeled marker. The results are in excellent agreement with those reported for radioligand binding assays. Therefore, the established MS Binding Assays are a promising alternative to the latter for the characterization of new monoamine reuptake inhibitors at DAT, NET, and SERT.Entities:
Keywords: binding assays; mass spectrometry; monoamine transporters; neurotransmitters; triple reuptake inhibitors
Mesh:
Substances:
Year: 2015 PMID: 25899387 DOI: 10.1002/cmdc.201500084
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466